Development and validation of LC/ESI-MS method for the detection and quantification of exogenous ceramide NP in stratum corneum and other layers of the skin

Journal of Pharmaceutical and Biomedical Analysis

Volumn 60, Issue , 2012, Pages 7-13

  Sahle, Fitsum F ^a   Lange, Stefan ^a   Dobner, Bodo ^a   Wohlrab, Johannes ^a   Neubert, Reinhard H H ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Ceramide; Deuterated ceramide NP; LC ESI MS; Skin; Stratum corneum

Indexed keywords

CERAMIDE; NANOPARTICLE;

ACCURACY; ARTICLE; BIOLOGICAL MONITORING; CHEMICAL ANALYSIS; CHEMICAL INTERACTION; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; COLUMN CHROMATOGRAPHY; CONCENTRATION (PARAMETERS); CORRELATION COEFFICIENT; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PURIFICATION; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; STRATUM CORNEUM; SUBCUTANEOUS TISSUE; SYNTHESIS; THIN LAYER CHROMATOGRAPHY; VALIDATION STUDY;

ADMINISTRATION, CUTANEOUS; CERAMIDES; CHROMATOGRAPHY, LIQUID; DEUTERIUM; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIMIT OF DETECTION; SKIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 83955161128     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.10.032     Document Type: Article

References (27)

1. Wartewig S., Neubert R.H. Properties of ceramides and their impact on the stratum corneum structure: a review. Part 1. Ceramides. Skin Pharmacol. Physiol. 2007, 20:220-229.
2. Stewart M.E., Downing D.T. A new 6-hydroxy-4-sphingenine-containing ceramide in human skin. J. Lipid Res. 1999, 40:1434-1439.
3. Masukawa Y., Narita H., Shimizu E., Kondo N., Sugai Y., Oba T., Homma R., Ishikawa J., Takagi Y., Kitahara T., Takema Y., Kita K. Characterization of overall ceramide species in human stratum corneum. J. Lipid Res. 2008, 49:1466-1476.
4. Mizutani Y., Mitsutake S., Tsuji K., Kihara A., Igarashi Y. Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie 2009, 91:784-790.
5. Mutanu Jungersted J., Hellgren L.I., Hogh J.K., Drachmann T., Jemec G.B., Agner T. Ceramides and barrier function in healthy skin. Acta Derm. Venereol. 2010, 90:350-353.
6. Lampe M.A., Williams M.L., Elias P.M. Human epidermal lipids: characterization and modulations during differentiation. J. Lipid Res. 1983, 24:131-140.
7. Cho Y., Lew B.L., Seong K., Kim N.I. An inverse relationship between ceramide synthesis and clinical severity in patients with psoriasis. J. Korean Med. Sci. 2004, 19:859-863.
8. Berardesca E., Barbareschi M., Veraldi S., Pimpinelli N. Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: a multicenter study. Contact Dermatitis 2001, 45:280-285.
9. Loden M. The skin barrier and use of moisturizers in atopic dermatitis. Clin. Dermatol. 2003, 21:145-157.
10. Proksch E., Jensen J.M., Elias P.M. Skin lipids and epidermal differentiation in atopic dermatitis. Clin. Dermatol. 2003, 21:134-144.
11. Raith K., Neubert R.H.H. Liquid chromatography-electrospray mass spectrometry and tandem mass spectrometry of ceramides. Anal. Chim. Acta 2000, 403:295-303.
12. Vietzke J.P., Strassner M., Hintze U. Separation and identification of ceramides in the human stratum corneum by high-performance liquid chromatography coupled with electrospray ionization mass spectrometry and electrospray multiple-stage mass spectrometry profiling. Chromatographia 1999, 50:15-20.
13. Farwanah H., Nuhn P., Neubert R., Raith K. Normal-phase liquid chromatographic separation of stratum corneum ceramides with detection by evaporative light scattering and atmospheric pressure chemical ionization mass spectrometry. Anal. Chim. Acta 2003, 492:233-239.
14. Farwanah H., Wohlrab J., Neubert R.H., Raith K. Profiling of human stratum corneum ceramides by means of normal phase LC/APCI-MS. Anal. Bioanal. Chem. 2005, 383:632-637.
15. van Smeden J., Hoppel L., van der Heijden R., Hankemeier T., Vreeken R.J., Bouwstra J.A. LC/MS analysis of stratum corneum lipids: ceramide profiling and discovery. J. Lipid Res. 2011, 52:1211-1221.
16. Bonte F., Pinguet P., Chevalier J.M., Meybeck A. Analysis of all stratum corneum lipids by automated multiple development high-performance thin-layer chromatography. J. Chromatogr. B Biomed. Appl. 1995, 664:311-316.
17. Farwanah H., Neubert R., Zellmer S., Raith K. Improved procedure for the separation of major stratum corneum lipids by means of automated multiple development thin-layer chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 780:443-450.
18. Cordis G.A., Yoshida T., Das D.K. HPTLC analysis of sphingomylein, ceramide and sphingosine in ischemic/reperfused rat heart. J. Pharm. Biomed. Anal. 1998, 16:1189-1193.
19. Scherer M., Leuthauser-Jaschinski K., Ecker J., Schmitz G., Liebisch G. A rapid and quantitative LC-MS/MS method to profile sphingolipids. J. Lipid Res. 2010, 51:2001-2011.
20. Kindt E., Wetterau J., Mueller S.B., Castle C., Boustany-Kari C.M. Quantitative sphingosine measurement as a surrogate for total ceramide concentration-preclinical and potential translational applications. Biomed. Chromatogr. 2010, 24:752-758.
21. Vietzke J.P., Brandt O., Abeck D., Rapp C., Strassner M., Schreiner V., Hintze U. Comparative investigation of human stratum corneum ceramides. Lipids 2001, 36:299-304.
22. Jessome L.L., Volmer D.A. Ion suppression: a major concern in mass spectrometry. LCGC N. Am. 2006, 24:498-511.
23. Kushner D.J., Baker A., Dunstall T.G. Pharmacological uses and perspectives of heavy water and deuterated compounds. Can. J. Physiol. Pharmacol. 1999, 77:79-88.
24. Annesley T.M. Ion suppression in mass spectrometry. Clin. Chem. 2003, 49:1041-1044.
25. Belleau B., Malek G. A new convenient reagent for peptide syntheses. J. Am. Chem. Soc. 1968, 90:1651-1652.
26. W.D.o.N. Resources Analytical Detection Limit Guidance & Laboratory Guide for Determining Method Detection Limits 1996, Wisconsin Department of Natural Resources Laboratory Certification Program.
27. EMEA Draft Guideline on Validation of Bioanalytical Methods 2009, European Medicines Agency, London.